Holen Sie sich die Stockscreener-App
3.48
2.25%
-0.08
Schlusskurs vom Vortag:
$3.56
Offen:
$3.51
24-Stunden-Volumen:
18,627
Relative Volume:
0.25
Marktkapitalisierung:
$13.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.52M
KGV:
-0.5505
EPS:
-6.3213
Netto-Cashflow:
$-1.14M
1W Leistung:
+0.29%
1M Leistung:
+21.25%
6M Leistung:
+12.62%
1J Leistung:
-83.38%
1-Tages-Spanne:
$3.43
$3.57
1-Wochen-Bereich:
$3.22
$3.58
52-Wochen-Spanne:
$0.6254
$34.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
Firmenname
Psyence Biomedical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare PBM vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
3.48 | 12.78M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelFactor Valuation - dars.gov.et
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Psyence Biomedical Ltd. Revenue Breakdown – NASDAQ:PBMWW - TradingView
PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update - TipRanks
Psyence BioMed (Nasdaq: PBM) outlines psilocybin and ibogaine clinical plans - Stock Titan
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Warrants (PBMWW) Surge 48%: A Closer Look at the Speculative MovePCR Spike - dars.gov.et
Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PBM|Psyence Biomedical Ltd|Price:2.950|Chg%:+0.130 - TradingKey
Psyence Biomedical Ltd (PBM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBM|Psyence Biomedical Ltd|Price:3.580|Chg%:+0.230 - tradingkey.com
Psyence Biomedical Ltd (PBM) Cash Flow - TradingKey
Psyence Biomedical Ltd (PBM) Balance Sheet - TradingKey
Psyence Biomedical Ltd (PBM) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBM) Dividends & Stock Splits: Historical Payouts and Event Timeline - tradingkey.com
PBM|Psyence Biomedical Ltd|Price:3.030|Chg%:+0.080 - TradingKey
Psyence Biomedical Ltd (PBM) Income Statement - TradingKey
Psyence Biomedical Company Profile & Introduction - Moomoo
Enterprise value to EBIT forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to earnings forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Enterprise value to revenue forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Psyence Biomedical Warrant (PBMWW) Surges 22% – Can Low-Priced Momentum Continue?Negative Gamma - dars.gov.et
Psyence Biomedical Ltd. (PBM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
PBMPsyence Biomedical Ltd Earnings - Finviz
Psyence Biomedical Ltd. (PBM) Retreats Amid Sector Caution: Support Levels Under ScrutinyIceberg Order - dars.gov.et
Tranche Update on Psyence Biomedical Ltd.'s Equity Buyback Plan announced on January 12, 2026. - marketscreener.com
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits
$Psyence Biomedical (PBM.US)$ - Moomoo
Psyence Biomedical (PBM) Drops Over 6% as Shares Test Key Support LevelsSocial Sentiment - po-news-eg.net
Psyence Biomedical (Nasdaq: PBM) outlines losses, cash runway and trial risks in 20-F - Stock Titan
Psyence Biomedical Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today - Stocktwits
PBMWW | Psyence Biomedical Ltd. Warrant Insider Trading - Quiver Quantitative
Psyence Biomedical Ltd (PBMWW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBMWW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Psyence Biomedical Ltd (PBMWW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBMWW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Ltd (PBMWW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBMWW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd (PBMWW) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBMWW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Psyence Biomedical Ltd (PBMWW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBMWW Warrants Slide 9.25% as Psyence Biomedical Faces Continued Selling PressureGamma Exposure - newsline.com
Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):